ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SNG Synairgen Plc

4.51
-0.135 (-2.91%)
Last Updated: 11:53:49
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.135 -2.91% 4.51 4.41 4.99 4.53 4.51 4.53 150,843 11:53:49
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.51 9.35M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.65p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,345,000 shares in issue. The market capitalisation of Synairgen is £9.35 million. Synairgen has a price to earnings ratio (PE ratio) of -0.51.

Synairgen Share Discussion Threads

Showing 14851 to 14873 of 99175 messages
Chat Pages: Latest  595  594  593  592  591  590  589  588  587  586  585  584  Older
DateSubjectAuthorDiscuss
20/7/2020
11:24
Simplistically,you could make analogies between this treatment and the use of RetrovirAZT for the AIDs virus.
steeplejack
20/7/2020
11:21
many people now will not want a vaccine

is the answer


feekl for people who sold to early this morning


so often see this at shares early sellers missing out on bigger rises

while have sold some myself to move money back to ncyt with the £5 billion governmen contract to be announced thinking if ncyt win some of it how good a rise might be seen there

bunz3
20/7/2020
11:04
O/t check NSF, about to explode as seller is done imo and hsbc took a good chunk there. As always dyor
jungmana
20/7/2020
10:59
Synairgen's SNG001 shows strong promise in COVID-19 trial
sikhthetech
20/7/2020
10:55
Home kits. Massive. Forget the vaccines nobody wants the dodgy baggage associated with Gates involvement.
tidy 2
20/7/2020
10:49
Valuation off the clock for Cv19 alone for Sng. U.K. Company’s Drug Cuts Covid-19 RiskShares of Synairgen Plc, a tiny pharmaceutical firm born out of a U.K. university, soared after the company said its experimental drug cut the risk of developing the worst symptoms of Covid-19.“Valuing the Covid-19 opportunity is nigh on impossible,â€? FinnCap analyst Mark Brewer said in a note to clients, adding that upcoming discussions with regulators should clarify SNG001’s route to market. Finncap is also corporate broker to the company.Synairgen, founded by three professors from the University of Southampton, previously partnered with AstraZeneca -Bloomberg
tidy 2
Chat Pages: Latest  595  594  593  592  591  590  589  588  587  586  585  584  Older

Your Recent History

Delayed Upgrade Clock